They can support your energy levels, but a balanced diet and regular exercise are key to losing weight effectively.
those with diabetes or obesity but no medication (300,000 patients in the study) Those on GLP-1 meds were 66% more likely to have gastroparesis 0.53% of patients had paralysis that is the equivalent of 1 in every 200 people on semaglutide or tirzepatide They were more likely to have nausea, vomition, or reflux and be prescribed a proton pump inhibitor They were more likely to have drug-induced pancreatitis and need gallbladder removal
Andrew Huberman, a neuroscience professor at Stanford, has stated publicly that "BPC-157 is one of the more interesting peptides because of the gastric juice origin and the acid stability, but the lack of human trials is a real limitation that people tend to overlook." This sentiment reflects the tension between preclinical promise and clinical evidence gaps
This is because of the several pollutants in the water and air, pesticides, and genetic modifications being added to the food animals consume daily
NAD+ repletion improves muscle function in muscular dystrophy and counters global [PMID: 27798264] Laboratory literature summary: NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation
The CagriSema program proved an amylin analog adds to a GLP-1 drug